Treatment of Letterer-Siwe disease.
D000403:Airway Resistance; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008170:Lung Compliance; D008297:Male; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011239:Prednisolone / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D010100:Oxygen